ContagionLive: Infectious Disease News and Expert Insight for Clinicians

ContagionLive, published as Contagion, is a United States digital news platform for infectious disease professionals, operated by MJH Life Sciences from Cranbury, New Jersey. It provides infectious disease news, outbreak coverage and expert insight for clinicians through its website, contagionlive.com, a quarterly digital journal, email newsletters and social media. Its contact address, published on its own site, is 259 Prospect Plains Road, Building H, Cranbury, NJ 08512.

The platform describes itself as a fully integrated news resource covering all areas of infectious disease. Its stated purpose is to give practitioners and specialists disease-specific information designed to improve patient outcomes and to assist with the identification, diagnosis, treatment and prevention of infectious diseases — and, more broadly, to assure that the health care community and the public have the knowledge to make more informed choices. That clinical, outcome-focused mission distinguishes ContagionLive from general health news sites.

Publisher: MJH Life Sciences of Cranbury

MJH Life Sciences is a privately held medical media company headquartered in Cranbury, New Jersey, and described as the largest privately held medical media company in North America. Its roots lie with founder Michael J. Hennessy Sr., who began in medical publishing after graduating from Rider University in 1982, became chief operating officer of Medical World Business Press in 1986, launched MultiMedia Healthcare in 1993 and built a portfolio of clinical journals before pioneering an integrated print and digital approach with Intellisphere, now part of MJH Life Sciences.

The modern company took its present scale in January 2019, when MJH acquired the UBM Life Sciences Group — more than twenty brands across healthcare, pharma and animal health markets, with seven offices and over 220 associates — making it the largest privately held medical media company in the United States. Its portfolio grew to more than fifty brands, over a thousand events, eight million unique monthly online visitors and two million print readers. In 2021 BDT Capital Partners agreed to acquire a majority interest, with the Hennessy family retaining a significant minority stake and Mike Hennessy Jr., president and chief executive since 2019, continuing to lead the company. Hennessy Sr. died on November 21, 2021, at the age of 61.

Audience: Infectious Disease Practitioners and Specialists

ContagionLive is written for the clinicians who manage infection: infectious disease physicians, clinical pharmacists, infection preventionists, microbiologists, hospitalists, primary care clinicians and other health care professionals who must identify, diagnose, treat and prevent infectious diseases in practice. Its professional social presence summarises the offer as timely infectious disease news, expert perspectives and practical insights for healthcare professionals.

That audience works under distinctive pressures. Pathogens emerge and re-emerge, resistance patterns shift, guidelines change, and a decision — which antibiotic, for how long, with what de-escalation plan — must often be made before complete data are available. A specialist news resource earns its place by shortening the distance between new evidence and the bedside: reporting a systematic review, a regulatory action or a public health advisory quickly, and surrounding it with commentary from clinicians who can explain what should actually change in practice.

News Coverage: Outbreaks, Approvals and Evidence

The news service is the platform's daily engine. ContagionLive publishes news articles, weekly roundups of the top infectious disease stories and quarterly reviews of the developments that defined a period. Its second-quarter 2026 review, for example, gathered regulatory milestones, outbreak events and pipeline advances — including a first United States approval in hepatitis delta virus, new HIV treatment options and a cruise ship outbreak that tested biopreparedness — into a single assessment of a consequential quarter for the field.

Individual news coverage follows the same evidence-led pattern. A weekly roundup story examined a systematic review and Bayesian meta-analysis revisiting whether the antibiotic cefepime raises mortality risk relative to other beta-lactam antibiotics, setting the findings against an earlier report and the Food and Drug Administration's investigation. Another item in the same roundup covered a surge in calls to the Centers for Disease Control and Prevention about potential rabies exposures and the agency's clinician outreach and health advisory, while a third addressed new diagnostics intended to streamline care for Legionella pneumonia. The selection — a prescribing question, a public health alert and a diagnostic advance — is characteristic of the mix clinicians need.

Clinical Depth: HIV and Antimicrobial Topics

HIV medicine is a substantial strand of coverage. ContagionLive carries expert panel discussions and peer exchange programmes in which specialists address simplifying HIV treatment in the presence of drug resistance, switching therapies for patients with a history of resistance, managing viral mutations, comparing integrase inhibitor regimens, interpreting real-world studies and patient-reported outcomes, and restarting therapy for patients who have fallen out of care. Contributors include infectious disease physicians and advanced practice clinicians speaking from programme experience, not only from trial data.

Antimicrobial stewardship is a second strand. Expert commentary on Candida auris — its concentration in long-term care patients with chronic conditions, its drug resistance and its burden in hospitals caring for transplant and intensive care patients — appears alongside guidance on managing asymptomatic bacteriuria appropriately, choosing shorter antibiotic courses and de-escalating therapy within forty-eight to seventy-two hours as laboratory data arrive. Reviews of diagnostics and treatment for underdiagnosed fungal infections such as histoplasmosis, and of new antibiotics assessed for resistant gonorrhoea, extend the same stewardship theme: use the right drug, for the right patient, for the right duration.

Conference Coverage and Expert Formats

ContagionLive maintains an extensive conference coverage archive, reporting from the meetings where infectious disease evidence is first presented, including the annual meeting of the Infectious Diseases Society of America. Its conference pages carry interviews and reports on subjects from point-of-care viral load testing and antiretroviral therapy in pregnancy to vaccine development, Zika virus research and respiratory syncytial virus pathogenesis, with speakers drawn from academic medical centres, children's hospitals and global health institutes.

Beyond news and conferences, the platform uses the standard MJH repertoire of expert formats: peer exchanges in which panels work through a clinical problem across multiple segments, video interviews with investigators, review articles that synthesise a topic such as fungal diagnostics, and curated article collections that let a reader follow a disease area over time. For a busy clinician, those formats convert a flood of primary literature into structured, attributable expert judgement — with speakers' views clearly presented as their own and disclaimers noting that they do not necessarily reflect an employer's position.

The Quarterly Journal and Integrated Channels

Contagion presents itself as fully integrated: website, quarterly digital journal, email newsletters and social media outlets working together. The quarterly journal gives longer, review-style material a collected home, while newsletters push time-sensitive items — approvals, advisories, outbreak developments — to subscribers who cannot monitor the field daily. The website organises material by news, articles and conferences, and maintains the practical apparatus of a professional publication, including about, advertising, editorial and contact pages.

Social distribution reinforces the model. The platform's professional network presence shares new reviews and analyses with several thousand followers, summarising, for example, an international study estimating actual and optimal use of the World Health Organization's Access, Watch and Reserve antibiotic classifications across 186 countries and regions. For infectious disease, where a guideline or outbreak notice may be clinically urgent, that multi-channel push is a service feature, not a marketing extra.

Disease Scope: From Everyday Infection to Emerging Threats

The scope implied by covering all areas of infectious disease is wide. In practice, ContagionLive's pages move between sexually transmitted infections and HIV, viral hepatitis, respiratory infections, fungal diseases, bacterial resistance, healthcare-associated infection, travel and tropical topics such as arboviruses, and public health emergencies. Historical conference coverage addressed Zika's arrival in the Americas in the 2015 Brazilian epidemic; recent coverage addresses rabies exposures from bats, beavers and river otters, Legionella in building water systems and the continuing Candida auris challenge in long-term care.

That breadth reflects the specialty itself, which sits at the intersection of individual patient care, hospital infection control and population health. An infectious disease clinician may consult on a transplant patient's bloodstream infection in the morning and advise on an institutional outbreak response in the afternoon. A publication serving that clinician must be equally comfortable with a meta-analysis, a Centers for Disease Control and Prevention advisory and a practical stewardship interview — and ContagionLive's structure is built to hold those registers together.

Editorial Values and Relationship to Practice

The platform's mission statement ties information to outcomes: disease-specific information designed to improve patient outcomes. Its profile features reinforce a service ethos — one recent piece celebrated a clinician's passion for infectious disease education and communication, quoting his advocacy of shorter courses, timely de-escalation and faster use of laboratory data to make smarter decisions. Education, in that telling, is itself a clinical intervention, multiplying one specialist's judgement across every reader's practice.

As part of MJH Life Sciences, ContagionLive also sits beside sister brands for other specialties and audiences — oncology, pharmacy, primary care and patient-facing titles among them — within a company whose stated vision since its establishment in 1998 has been to share health and expert knowledge broadly to improve care. Cross-brand infrastructure gives a single-specialty platform professional production, events and distribution resources that an independent newsletter could not sustain.

Why ContagionLive Matters

Infectious disease is the specialty where news most directly changes practice: a resistance report, an approval, an advisory or an outbreak can alter what a clinician does the same week. ContagionLive exists to make that change informed rather than improvised, gathering news, conference evidence and expert interpretation in one Cranbury-published, clinician-focused resource.

For WorldNM's online news directory, it represents the modern specialist medical platform at its most developed — no print legacy to maintain, but a quarterly journal, daily web news, newsletters, video panels and conference reporting integrated around a single specialty. Its endurance within the MJH portfolio, and the scale of the audience that portfolio delivers across medicine, make ContagionLive a significant United States source for the professionals who identify, diagnose, treat and prevent infectious disease.